Last $26.64 USD
Change Today -0.93 / -3.37%
Volume 1.9M
ACAD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger G. Mills M.D.

Chief Medical Officer and Executive Vice President of Development, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

56$2,876,294
As of Fiscal Year 2013

Background*

Dr. Roger G. Mills, M.D. has been an Executive Vice President of Development at Acadia Pharmaceuticals Inc., since June 30, 2006 and also serves as its Chief Medical Officer. Dr. Mills is responsible for leading ACADIA's global drug development activities. He has more than 18 years of experience in the pharmaceutical industry. He served as Vice President of Development at Pfizer Global R&D, a division of Pfizer Inc., for a five-year period. He was responsible for the ...

Read Full Background

Corporate Headquarters*

11085 Torreyana Road
San Diego, California 92121

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
Charing Cross & Westminster Medical School London

Other Affiliations*

Annual Compensation*

Salary$405,000
Bonus$200,000
Total Annual Compensation$605,000

Stock Options*

All Other Compensation$13,689
Exercised Options35,965
Exercised Options Value$843,739
Exercisable Options598,409
Unexercisable Options340,626
Total Value of Options$843,739
Total Number of Options975,000

Total Compensation*

Total Annual Cash Compensation$618,689
Total Short Term Compensation$605,000
Other Long Term Compensation$13,689
Total Calculated Compensation$2,876,294
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $26.64 USD -0.93

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.